Perbedaan Budi Starch Sweetener Tbk dan Diagnos Laboratorium Utama Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp220 (kapitalisasi pasar 980,78 M, volume 24 jam 483 rb), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,7 rb). Perbedaan utamanya: Budi Starch Sweetener Tbk jauh lebih besar — sekitar 3,1× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Budi Starch Sweetener Tbk lebih aktif diperdagangkan (483 rb vs 41,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BUDI | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 980,78 M | 316,25 M |
Volume | 483 rb | 41,7 rb |
Lot | 4,83 rb | 417 |
Perputaran | 107,13 jt | 9,66 jt |
Harga Rata-rata | 221,8 | 231,65 |
Nilai Transaksi | 107,13 jt | 9,66 jt |
Harga Ekuilibrium Indikatif | 224 | 230 |
Volume Ekuilibrium Indikatif | 12 | 2,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Selengkapnya di halaman BUDI →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →